TY - JOUR
T1 - Non-demented individuals with Alzheimer’s disease neuropathology
T2 - Resistance to cognitive decline may reveal new treatment strategies
AU - Zolochevska, Olga
AU - Taglialatela, Giulio
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/7/1
Y1 - 2016/7/1
N2 - Alzheimer’s disease (AD) is a terminal neurodegenerative disorder that is characterized by accumulation of amyloid plaques and neurofibrillary tangles in the central nervous system. However, certain individuals remain cognitively intact despite manifestation of substantial plaques and tangles consistent with what would be normally associated with fully symptomatic AD. Mechanisms that allow these subjects to escape dementia remain unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. In this review article we discuss potential compensatory mechanisms that allow these individuals to remain cognitively intact despite the typical AD neuropathology.
AB - Alzheimer’s disease (AD) is a terminal neurodegenerative disorder that is characterized by accumulation of amyloid plaques and neurofibrillary tangles in the central nervous system. However, certain individuals remain cognitively intact despite manifestation of substantial plaques and tangles consistent with what would be normally associated with fully symptomatic AD. Mechanisms that allow these subjects to escape dementia remain unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. In this review article we discuss potential compensatory mechanisms that allow these individuals to remain cognitively intact despite the typical AD neuropathology.
KW - Alzheimer’s disease
KW - Compensatory mechanisms in AD
KW - Non-demented with Alzheimer’s Neuropathology
KW - Resistance to cognitive decline
UR - http://www.scopus.com/inward/record.url?scp=84983775249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983775249&partnerID=8YFLogxK
U2 - 10.2174/1381612822666160518142110
DO - 10.2174/1381612822666160518142110
M3 - Review article
C2 - 27189599
AN - SCOPUS:84983775249
SN - 1381-6128
VL - 22
SP - 4063
EP - 4068
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 26
ER -